Mcdermott Will & Emery LLP (Obo Alnylam Pharmaceuticals)

Biopharmaceuticals.

Based in CA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $300K in lobbying spend across 6 quarterly filings, Mcdermott Will & Emery LLP (Obo Alnylam Pharmaceuticals) is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2022 to 2023.

$300K
Total Spend
2
Years Active
1
Firms Hired
6
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2022$260K
2023$40K

Issues Lobbied

Copyright/PatentHealth IssuesMedicare/Medicaid

Lobbying Firms

Tiber Creek Group

Lobbyists

Timothy MolinoJohn GonzalezCorey MalmgrenJonathon JonesBryant HallTimothy Robinson

Government Agencies Targeted

These are the government entities that Mcdermott Will & Emery LLP (Obo Alnylam Pharmaceuticals) disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATE
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Copyright/Patent, Health Issues, Medicare/Medicaid

Issues related to COVID-19 vaccines.

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169).

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Tech Lobbying
Industry overview and top spenders
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Who's Lobbying to Shape AI Policy
The AI regulation fight is the biggest lobbying battle of the decade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Invitae INC.
$1.8M total spend
Kaiser Foundation Health Plan INC
$31.5M total spend
Jazz Pharmaceuticals, INC.
$11.5M total spend
Biomarin Pharmaceutical INC.
$9.6M total spend
Acadia Pharmaceuticals
$7.3M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.